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ABSTRACT
Objective: Mycobacterium tuberculosis, one of the deadliest human pathogens, causes several million new infections and about 2 million fatalities 
annually. The cell wall of M. tuberculosis is endowed with a highly impermeable, complex array of diverse lipids such as mycolic acids, which bestow 
the bacterium with not only virulence but also resistance to host immunity and antibiotics.
Methods: Mycobacterial lipid metabolism has thus emerged as an attractive target for the design and development of novel antimycobacterial 
therapeutics. The first committed step in the biosynthesis of mycolic acid is the carboxylation of acetyl-CoA to malonyl-CoA which is catalyzed by acetyl-
coenzyme A carboxylase carboxyl transferase beta subunit (accD3), a primer pairs were designed computationally and used for the amplification of 
accD3 gene using conventional polymerase chain reaction (PCR) and sequencing the PCR product and analyze the results.
Results: Two sequences of the detection gene (LprM gene) and eight sequences of accD3 gene under study were deposited at NCBI – GenBank 
database with accession numbers (LC009881, LC009880.1, LC006979, LC008196, LC009412, LC009414, LC034168, LC038020, LC041163, and 
LC041368) and primer pairs deposited at Probe database/NCBI with accession number Pr032816836.
Conclusion: AccD3 gene is a good drug target in MDR M. tuberculosis strains.
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INTRODUCTION
Tuberculosis (TB) is a debilitating and highly contagious disease that 
primarily affects the lungs. It was declared by a global health emergency 
in 1993 by the World Health Organization when approximately 8 million 
TB cases were estimated, and 1.3–1.6 million deaths occurred from the 
disease every year, now TB exacerbated by the spread of AIDS [1,2].
AccD3 gene, one of the virulent factors, plays a key role in the 
biosynthesis pathway of cell wall mycolic acid, and the product of 
this gene is acetyl-CoA carboxylase carboxyl transferase beta subunit 
enzyme which is one of the Acc groups. Currently, there are no examples 
of antibacterial Acc inhibitors in clinical use as antibiotics [3-5]; 
therefore, accD3 represents a very good target for drugs [6].
The aim of this study is to investigate this gene in Iraqi isolates, to be 
used later for drug design or discovery.
METHODS
DNA extraction from Mycobacterium tuberculosis isolates and 
primer design
A total of 50 mycobacterial cultures were collected from the Institute 
of Chest and Respiratory Disease in Baghdad/Iraq, from May to July 
2013. DNA was extracted from prediagnosed mycobacterial cultures 
and purified by CTAB method [7,8]. M. tuberculosis isolates were 
characterized at molecular level using LprM gene, and two sequences 
of LprM gene were deposited at GenBank database with accession 
numbers (LC009880.1 and LC009881), primer pairs were used to 
amplify this gene to differentiate M. tuberculosis from the other types of 
mycobacteria [9]. The results showed that 43 isolates (86%) among of 
50 isolates were M. tuberculosis.
DNA sequences of accD3 (1488 bp) were retrieved from public 
database; primers were designed for the gene at two positions, 
Segment I from 38 to 831 to give polymerase chain reaction (PCR) 
product 793 bp and Segment II from 631 to 1482 to give PCR product 
851 bp. There was an overlapped sequence about 300 bp which was 
curated manually. The resulted sequence covered the region from 39 
to 1482, these were aligned using Clustal W, and phylogenetic tree was 
built using NJ method, all these sequences were deposited at NCBI/
nucleotide (GenBank database) with accession numbers (LC006979, 
LC008196, LC009412, LC009414, LC034168, LC038020, LC041163, 
and LC041368).
The primer sequences used in PCR experiments are deposited at Probe 
database/NCBI with accession number (Pr032816836) shown in 
Table 1.
Amplification of target gene
AccD3 gene segments (SI and SII) were amplified separately. Each PCR 
mixture was prepared with 25 µl of Green Master Mix ×2 (Promega), 
17 µl of nuclease free water, 2 µl of each primer (F,R) at 10 µM, and 4 µl 
of DNA (equaling 25–250 ng). Multiple PCR programs were used until 
reach to the optimum program which gives a good PCR product, the 
thermocycling conditions for SI and SII were 94°C for 5 min, followed 
by 35 cycles of denaturation at 94°C for 1 min, and annealing at 59°C 
for 1.30 min and 72°C for 1 min, then the final extension steps at 72°C 
for 10 min.
PCR amplified products (10 µl) and DNA molecular-weight marker 
(Ladder) were electrophorized on 1% agarose gel with ethidium 
bromide staining to verify the size of the amplicon, the resulted PCR 
products were sequenced (NICEM-USA, Apparatus: Applied Biosystem).
RESULTS AND DISCUSSION
M. tuberculosis contains multiple versions of accD genes that encode 
α and β subunits of at least three distinct multifunctional acyl-CoA 
carboxylase complexes [10,11]. The function of a number of genes 
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involved in fatty acid and mycolic acid biosynthesis is known for their 
role in the survival of pathogenic M. tuberculosis [12-14]. A primer pairs 
for β subunit were designed and used in the amplification of this gene 
after segmentation of this big gene using conventional PCR technique, 
the resulted 30 samples were positive out of 43 samples. Amplified 
accD3 gene (SI and SII) results are shown in Fig. 1.
The PCR product for the two segments of eight isolates was sequenced 
and in silico analyzed to prove the conformity with accD3 gene 
sequences of other M. tuberculosis strains in the public databases, 
Segment I (SI) and Segment II (SII) sequences were BLASTed at 
expected threshold value 0.05 using BLASTn program and Nucleotide 
Collection (nt/nr) database. The results showed these sequences lie in 
M. tuberculosis strains with identity 98–99% as shown in Figs. 2 and 3, 
and the clustering results of these sequences with other Mycobacterium 
strains are shown in Figs. 4 and 5.
There was an overlap sequence with length about 300 bp between SI 
and SII, this was removed and merged using Mega 6 and merger tools at 
EMBOSS package (http://emboss.bioinformatics.nl/cgi-bin/emboss/
merger) [15] to obtain the whole curated sequence. The obtained 
sequences of accD3 were BLASTed with other strains in GenBank 
database at E. value 0.00, and the results were showed that the query 
sequences were matched the accD3 sequences in the databases with 
query cover 100% and identity percentage 99%. Table 2 summarizes 
the results of BLAST program (nucleotide Blast) for the eight obtained 
accD3 sequences which were designated as (ALQM1, ALQM2, ALQM3, 
ALQM4, ALQM5, ALQM6, ALQM7, and ALQM8).
AccD3 (Rv0904c) sequences (ALQM1, ALQM2, ALQM3, ALQM4, 
ALQM5, ALQM6, ALQM7, and ALQM8) as a group (Iraqi strains) were 
clustered with other strains isolated from different countries (the USA, 
Russia, India, Japan, India, and Colombia) and registered in NCBI and 
DDBJ databases. The genetic changes were between the members of 
phylogenetic tree was 0.02 and the query sequences distributed on 
different sites. Fig. 6 shows the phylogenetic tree of accD3 nucleotide 
sequences, using nucleotide sequences.
accD3 sequence translated into protein sequence and the resulted 
protein sequences were aligned with others in the public database 
using Uniprot database/Blast (http://www.uniprot.org/blast/). The 
protein BLAST results are summarized in Table 3.
According to our knowledge, this is the 1st time to design primer pairs 
for accD3, and the results showed that the designed primer in this study 
might be efficient and realistic for the detection of this gene.
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Table 1: Primer pairs for accD3 gene segments (used in this study)
Segment I (SI) (38–831) Forward GCTAGACCGGGGATCTTTCG PCR product 793bp
Reverse GCCTTGATCGGTTCCTGACA
Segment II (SII) (631–1482) Forward TGAGTTGCTCTATGGCGACC PCR product 851bp
Reverse GACAGTCGTAGGGCGAACTC
PCR: Polymerase chain reaction
Table 2: BLASTing results of accD3 sequences
Strain number E value Identity (100%) Max score, total score Query cover (%) Accession number of similarities strains and 
range
ALQM1 0.0 99 2710,2710 100 HG813240.1
3042536 to 3044023
ALQM2 0.0 99 2732,2732 100 CP009100.1
1006688 to 1008175
ALQM3 0.0 99 2732,2732 100 CP007299.1
1004529 to 1006016
ALQM4 0.0 99 2693,2693 100 CP007027.1
1006696 to 1008183
ALQM5 0.0 99 2473,2473 99 AP014573.1
1010903 to 1012244
ALQM6 0.0 99 2405,2405 99 CP009480.1
1003854 to 1005193
ALQM7 0.0 99 2416,2416 99 CP009480.1
1003854 to 1005194
ALQM8 0.0 99 2447,1447 98 HG813240.1
1005257 to 1006587
Table 3: The BLAST results of accD3 protein sequences with 
others in Uniprot database
Strain 
number
E-value Identity Accession number of 
subject (protein strains)
ALQM1 0.0 100 A0A097ZPG9
ALQM2 0.0 100 A0A097ZP91
ALQM3 0.0 100 A0A0A1GNR9
ALQM4 0.0 100 A0A0A1GN94
ALQM5 0.0 99.6 A0A097ZPG9
ALQM6 0.0 97.8 A0A0A1GNR9
ALQM7 0.0 98.4 A0A0A1GNR9
ALQM8 0.0 99.6 A0A056FNG1
Fig. 1: Gel electrophoresis of accD3 (SI and SII) using 1% agarose 
staining with ethidium bromide
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